Effective August 8, 2022, the Board of Directors of OncoCyte Corporation appointed Gisela Paulsen to the position of President and Chief Operating Officer. Gisela Paulsen, 56, previously served as Chief Operating Officer since October 2021. Prior to joining Oncocyte, Ms. Paulsen was the General Manager, Precision Oncology of Exact Sciences Corporation, a molecular diagnostics company specializing in the detection of early stage cancers, from April 2020 to April 2021.

Prior to joining Exact Sciences, Ms. Paulsen served in various management roles at F. Hoffmann-La Roche Ltd. (“Roche”), a multinational healthcare company, and Genentech Inc. (“Genentech”), a biotechnology company which became a subsidiary of Roche, since November 2005. She served as Roche and Genentech's Senior Vice President, Global Head, Product Development, Clinical Operations from January 2018 to April 2020, as Roche and Genentech's Vice President, Global Head, Product Development, Global Product Strategy & Late-Stage Portfolio Finance beginning from March 2017 to February 2018, and as Genentech's Vice President, Access Solutions from September 2014 to February 2017. Ms. Paulsen received a B.S. in pharmacy and an M.S. in pharmaceutics and drug delivery from Uppsala University in Sweden.